Amalgamated Bank’s Ascendis Pharma A/S ASND Stock Holding History

Amalgamated Bank’s Portfolio ASND Stock Details ASND Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$965K	Buy	+3,619	New	+$845K	0.01%	1125

Other funds holding ASND

ARS Investment Partners New York $2.29B AUM 113.95% 1-Year Est. Return

Sapient Capital Indianapolis, Indiana $7.64B AUM 51.51% 1-Year Est. Return

Synergy Asset Management Vancouver, Washington $1.06B AUM 36.26% 1-Year Est. Return

Handelsbanken Fonder

Handelsbanken Fonder Stockholm, Sweden $35.1B AUM 47.76% 1-Year Est. Return

Diversified Trust Memphis, Tennessee $6.24B AUM 28.78% 1-Year Est. Return

Police & Firemen's Retirement System of New Jersey Trenton, New Jersey $13.3B AUM 45.46% 1-Year Est. Return

Henry James International Management New York $334M AUM 49.44% 1-Year Est. Return

Mediolanum International Funds Dublin 1, Ireland $11.7B AUM 47.18% 1-Year Est. Return

Fideuram - Intesa Sanpaolo Private Banking Turin $3.33B AUM

China Universal Asset Management Company Shanghai, China $1.67B AUM 89% 1-Year Est. Return

Amalgamated Bank's ASND Position: Q2 2026 in Review

Amalgamated Bank opened a new position in Ascendis Pharma A/S (ASND) in Q2 2026: 3,619 shares worth $965K. The stake represents 0.01% of the portfolio and ranks #1125 among its holdings.

34 funds tracked by Wall St. Rank hold ASND as of Q2 2026.

Amalgamated Bank held 3,619 shares of Ascendis Pharma A/S worth $965K as of Q2 2026.
Ascendis Pharma A/S was a new Amalgamated Bank position in Q2 2026.
Ascendis Pharma A/S made up 0.01% of Amalgamated Bank's portfolio in Q2 2026, its #1125 holding.
34 funds tracked by Wall St. Rank held Ascendis Pharma A/S as of Q2 2026.

Based on Amalgamated Bank's 13F filing for Q2 2026, filed 23 Jul 2026.